Biogen Inc.
Biogen Inc. (IDP.DE) Stock Competitors & Peer Comparison
See (IDP.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| IDP.DE | €153.06 | +3.38% | 22.5B | 20.40 | €7.52 | N/A |
| LLY.DE | €787.20 | -1.11% | 749.1B | 40.31 | €19.67 | +0.68% |
| JNJ.DE | €203.70 | +1.02% | 491.6B | 21.58 | €9.46 | +2.18% |
| 4AB.DE | €178.25 | +2.35% | 312.5B | 87.45 | €2.02 | +3.24% |
| 6MK.DE | €101.86 | -0.22% | 251.9B | 16.33 | €6.24 | +2.79% |
| ZEG.DE | €160.70 | +0.59% | 249.2B | 28.75 | €5.59 | +1.69% |
| AMG.DE | €299.65 | +0.94% | 160.1B | 24.31 | €12.22 | +2.78% |
| GIS.DE | €119.42 | +1.84% | 147.8B | 20.53 | €5.80 | +2.30% |
| PFE.DE | €23.03 | +0.46% | 131.5B | 19.93 | €1.16 | +6.35% |
| PFE.F | €23.03 | +0.20% | 131.5B | 19.93 | €1.16 | +6.36% |
Stock Comparison
IDP.DE vs LLY.DE Comparison April 2026
IDP.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDP.DE stands at 22.5B. In comparison, LLY.DE has a market cap of 749.1B. Regarding current trading prices, IDP.DE is priced at €153.06, while LLY.DE trades at €787.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDP.DE currently has a P/E ratio of 20.40, whereas LLY.DE's P/E ratio is 40.31. In terms of profitability, IDP.DE's ROE is +0.07%, compared to LLY.DE's ROE of +0.98%. Regarding short-term risk, IDP.DE is less volatile compared to LLY.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IDP.DE.Check LLY.DE's competition here